High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis.

[1]  O. Yang,et al.  Hdl Redox Activity is Increased in HIV-Infected Men in Association with Macrophage Activation and Non-Calcified Coronary Atherosclerotic Plaque , 2014, Antiviral therapy.

[2]  C. Nordeen.  Associations Between HIV infection and Subclinical Coronary Atherosclerosis , 2014 .

[3]  J. DiNicolantonio,et al.  Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. , 2014, Thrombosis research.

[4]  P. Meikle,et al.  Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease. , 2014, European heart journal cardiovascular Imaging.

[5]  Richard D Moore,et al.  Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Jeroen J. Bax,et al.  Prognostic value of aortic and mitral valve calcium detected by contrast cardiac computed tomography angiography in patients with suspicion of coronary artery disease. , 2014, The American journal of cardiology.

[7]  Seung‐Jung Park,et al.  Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus. , 2014, The American journal of cardiology.

[8]  M. McCarter,et al.  Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Ex vivo , 2014, Retrovirology.

[9]  G. d’Ettorre,et al.  Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin , 2013, ISRN AIDS.

[10]  F. Madeo,et al.  Cell death pathways. , 2013, Biochimica et biophysica acta.

[11]  M. J. Kasten,et al.  Human immunodeficiency virus: what primary care clinicians need to know. , 2013, Mayo Clinic proceedings.

[12]  G. Raff,et al.  Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. , 2013, European heart journal cardiovascular Imaging.

[13]  S. Abbara,et al.  Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men , 2013, AIDS.

[14]  F. Gaita,et al.  Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. , 2013, European heart journal.

[15]  K. Dabhadkar,et al.  Polypill strategy for primary prevention of cardiovascular disorders. , 2013, Drugs of today.

[16]  J. Mallolas,et al.  Differences between HIV‐infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case–control studies , 2013, HIV medicine.

[17]  F. Gaita,et al.  Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. , 2013, Atherosclerosis.

[18]  A. Westfall,et al.  Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  F. Pereyra,et al.  Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers , 2012, AIDS.

[20]  Matthias F Kriegel,et al.  Differentiation of early from advanced coronary atherosclerotic lesions: systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. , 2012, Radiology.

[21]  S. Abbara,et al.  Receptor Activator of Nuclear Factor-&kgr;B Ligand (RANKL) and Its Relationship to Coronary Atherosclerosis in HIV Patients , 2012, Journal of acquired immune deficiency syndromes.

[22]  Jeffrey N. Martin,et al.  A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis , 2012, AIDS.

[23]  F. Gaita,et al.  Coronary artery disease Acute coronary syndromes in human immunodeficiency virus patients : a meta-analysis investigating adverse event rates and the role of antiretroviral therapy , 2012 .

[24]  H. Masur,et al.  Non-Calcified Coronary Plaque Volume Inversely Related to Cd4+ T-Cell Count in HIV Infection , 2011, Antiviral therapy.

[25]  E. Rosenberg,et al.  Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. , 2011, The Journal of infectious diseases.

[26]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[27]  M. Budoff,et al.  Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography. , 2011, The American journal of cardiology.

[28]  E. Rosenberg,et al.  Soluble CD 163 , a Novel Marker of Activated Macrophages , Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected Patients , 2011 .

[29]  S. Abbara,et al.  Increased Coronary Artery Calcium Score and Noncalcified Plaque Among HIV-Infected Men: Relationship to Metabolic Syndrome and Cardiac Risk Parameters , 2010, Journal of acquired immune deficiency syndromes.

[30]  S. Abbara,et al.  Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men , 2010, AIDS.

[31]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[32]  R. Kronmal,et al.  Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study , 2009, AIDS.

[33]  A. Sharrett,et al.  Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men , 2008, AIDS.

[34]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[35]  S. Abbara.  Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups , 2008 .

[36]  Hirofumi Anno,et al.  Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. , 2007, Journal of the American College of Cardiology.

[37]  W. K. Henry,et al.  Progression of carotid artery intima–media thickening in HIV-infected and uninfected adults , 2007, AIDS.

[38]  Renu Virmani,et al.  Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[39]  M. Hadamitzky,et al.  Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. , 2006, Journal of the American College of Cardiology.

[40]  Jeffrey N. Martin,et al.  Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection , 2004, Circulation.

[41]  Katherine C. Wu,et al.  Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. , 2002, American heart journal.

[42]  R. Talwani,et al.  Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. , 2002, Journal of acquired immune deficiency syndromes.

[43]  J. Ornato,et al.  Acute coronary syndromes , 2002 .

[44]  I. Olkin,et al.  Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement , 2000, Revista espanola de salud publica.

[45]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[46]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[47]  The Progression of Atherosclerosis , 1985, The Lancet.